Recent molecular and genetic evidence suggest that sarcomatoid component is transformed from a common progenitor of the associated renal cell carcinoma, and the TP53 gene plays a pivotal role in this process. This evidence concerns the gene TP53 and hereditary clear cell renal cell carcinoma.